|
1
|
Ross B, McKendy K and Giaid A: Role of
urotensin II in health and disease. Am J Physiol Regul Integr Comp
Physiol. 298:R1156–R1172. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ames RS, Sarau HM, Chambers JK, Willette
RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF,
Coatney RW, et al: Human urotensin-II is a potent vasoconstrictor
and agonist for the orphan receptor GPR14. Nature. 401:282–286.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Totsune K, Takahashi K, Arihara Z, Sone M,
Satoh F, Ito S, Kimura Y, Sasano H and Murakami O: Role of
urotensin II in patients on dialysis. Lancet. 358:810–811. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Matsushita M, Shichiri M, Imai T, Iwashina
M, Tanaka H, Takasu N and Hirata Y: Co-expression of urotensin II
and its receptor (GPR14) in human cardiovascular and renal tissues.
J Hypertens. 19:2185–2190. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ban Y, Watanabe T, Suguro T, Matsuyama TA,
Iso Y, Sakai T, Sato R, Idei T, Nakano Y, Ota H, et al: Increased
plasma urotensin-II and carotid atherosclerosis are associated with
vascular dementia. J Atheroscler Thromb. 16:179–187. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Z, Xu J, Ye Y, Li Y, Gong H, Zhang G,
Wu J, Jia J, Liu M, Chen Y, et al: Urotensin II inhibited the
proliferation of cardiac side population cells in mice during
pressure overload by JNK-LRP6 signalling. J Cell Mol Med.
18:852–862. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tzanidis A, Hannan RD, Thomas WG, Onan D,
Autelitano DJ, See F, Kelly DJ, Gilbert RE and Krum H: Direct
actions of urotensin II on the heart: Implications for cardiac
fibrosis and hypertrophy. Circ Res. 93:246–253. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi L, Ding W, Li D, Wang Z, Jiang H,
Zhang J and Tang C: Proliferation and anti-apoptotic effects of
human urotensin II on human endothelial cells. Atherosclerosis.
188:260–264. 2006. View Article : Google Scholar
|
|
9
|
Zhang YG, Li J, Li YG and Wei RH:
Urotensin II induces phenotypic differentiation, migration, and
collagen synthesis of adventitial fibroblasts from rat aorta. J
Hypertens. 26:1119–1126. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhao J, Ding W, Song N, Dong X, Di B, Peng
F and Tang C: Urotensin II-induced collagen synthesis in cultured
smooth muscle cells from rat aortic media and a possible
involvement of transforming growth factor-β1/Smad2/3 signaling
pathway. Regul Pept. 182:53–58. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bousette N, Pottinger J, Ramli W, Ohlstein
EH, Dhanak D, Douglas SA and Giaid A: Urotensin-II receptor
blockade with SB-611812 attenuates cardiac remodeling in
experimental ischemic heart disease. Peptides. 27:2919–2926. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press; Washington (DC): 2011
|
|
13
|
Ma L, Liu J, Chu N, et al: The
relationship between cardiac hypertrophy index and cardiac function
in chronic heart failure rats. J Capit Med Univ (Chin). 31:596–599.
2010.
|
|
14
|
Kehat I and Molkentin JD: Molecular
pathways underlying cardiac remodeling during pathophysiological
stimulation. Circulation. 122:2727–2735. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Berenji K, Drazner MH, Rothermel BA and
Hill JA: Does load-induced ventricular hypertrophy progress to
systolic heart failure? Am J Physiol Heart Circ Physiol.
289:H8–H16. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Creemers EE and Pinto YM: Molecular
mechanisms that control interstitial fibrosis in the
pressure-overloaded heart. Cardiovasc Res. 89:265–272. 2011.
View Article : Google Scholar
|
|
17
|
Bayer AL, Heidkamp MC, Patel N, Porter MJ,
Engman SJ and Samarel AM: PYK2 expression and phosphorylation
increases in pressure overload-induced left ventricular
hypertrophy. Am J Physiol Heart Circ Physiol. 283:H695–H706. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lapp H, Boerrigter G, Costello-Boerrigter
LC, Jaekel K, Scheffold T, Krakau I, Schramm M, Guelker H and
Stasch JP: Elevated plasma human urotensin-II-1ike immunoreactivity
in ischemic cardiomyopathy. Int J Cardiol. 94:93–97. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Russell FD, Meyers D, Galbraith AJ, Bett
N, Toth I, Kearns P and Molenaar P: Elevated plasma levels of human
urotensin-II immunoreactivity in congestive heart failure. Am J
Physiol Heart Circ Physiol. 285:H1576–H1581. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tran L, Kompa AR, Kemp W, Phrommintikul A,
Wang BH and Krum H: Chronic urotensin-II infusion induces diastolic
dysfunction and enhances collagen production in rats. Am J Physiol
Heart Circ Physiol. 298:H608–H613. 2010. View Article : Google Scholar
|
|
21
|
Dai HY, Kang WQ, Wang X, Yu XJ, Li ZH,
Tang MX, Xu DL, Li CW, Zhang Y and Ge ZM: The involvement of
transforming growth factor-beta1 secretion in urotensin II-induced
collagen synthesis in neonatal cardiac fibroblasts. Regul Pept.
140:88–93. 2007. View Article : Google Scholar
|
|
22
|
Dai HY, He T, Li XL, Xu Wl and Ge ZM:
Urotensin-2 promotes collagen synthesis via ERK1/2-dependent and
ERK1/2-independent TGF-β1 in neonatal cardiac fibroblasts. Cell
Biol Int. 35:93–98. 2011. View Article : Google Scholar
|
|
23
|
Domínguez-Rodríguez A, Díaz I,
Rodríguez-Moyano M, Calderón-Sánchez E, Rosado JA, Ordóñez A and
Smani T: Urotensin-II signaling: Mechanism in rat coronary artery:
Role of STIM1 and Orai1-dependent store operated calcium influx in
vasoconstriction. Arterioscler Thromb Vasc Biol. 32:1325–1332.
2012. View Article : Google Scholar
|
|
24
|
Song QG, Lü JZ and Yang JX: Effect of
urotensin II on the proliferation of cardiac Myofibroblasts and its
intracellular signaling mechanism in new-born SD rats. J Xi'an
Jiaotong Univ. 28:157–160. 2007.
|
|
25
|
Kemp W, Kompa A, Phrommintikul A, Herath
C, Zhiyuan J, Angus P, McLean C, Roberts S and Krum H: Urotensin II
modulates hepatic fibrosis and portal hemodynamic alterations in
rats. Am J Physiol Gastrointest Liver Physiol. 297:G762–G767. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rossowski WJ, Cheng BL, Taylor JE, Datta R
and Coy DH: Human urotensin II-induced aorta ring contractions are
mediated by protein kinase C, tyrosine kinases and Rho-kinase:
Inhibition by somatostatin receptor antagonists. Eur J Pharmacol.
438:159–170. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang YG, Li YG, Liu BG, Wei RH, Wang DM,
Tan XR, Bu DF, Pang YZ and Tang CS: Urotensin II accelerates
cardiac fibrosis and hypertrophy of rats induced by isoproterenol.
Acta Pharmacol Sin. 28:36–43. 2007. View Article : Google Scholar
|
|
28
|
Staudt Y, Mobini R, Fu M, Felix SB, Kühn
JP and Staudt A: Beta1-adrenoceptor antibodies induce apoptosis in
adult isolated cardiomyocytes. Eur J Pharmacol. 466:1–6. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li CJ and Han QH: Effect of Urotensin II
on cardiac function in heart failure rats and its mechanism of
action. Chinese J Integr Med Cardio Cerebrovasc Dis. 6:38–40.
2008.
|
|
30
|
Han QH, Liu WY, Li CJ, Wang R and Shi HT:
The effect of urotensin II on cardiac function of rats and its
electrophysiological mechanism. Chinese J Integr Med Cardio
Cerebrovasc Dis. 9:1479–1481. 2011.
|
